Azurity Pharmaceuticals
Woburn, Massachusetts, United States · Biotechnology, Health Care, Manufacturing
Azurity is a privately-held pharmaceutical company specializing in providing innovative, high-quality medicines that serve overlooked patients. Azurity supplies a large number of products to treat a wide range of medical conditions. These include cardiovascular, central nervous system, endocrine, gastro-intestinal, anti-infective and oncology medicines. Many of Azurity's medicines are dose-form in
Key facts
- Headquarters
- Woburn, Massachusetts, United States
- Employees
- 596
- Industries
- Biotechnology, Health Care, Manufacturing
- Status
- Private
- Website
- azurity.com
- Company page
Recent activity at Azurity Pharmaceuticals
- : Azurity Pharmaceuticals Completes Acquisition of Covis Pharma (date Fundz recorded it)
- : Azurity Pharmaceuticals acquires Covis Pharma
- : Azurity Pharmaceuticals Launches Azmiro™, the First FDA-Approved Prefilled Testosterone Cypionate Injection for Replacement Therapy.
- : Azurity Pharmaceuticals Acquires Slayback Pharma
Dates are the day the event happened, taken from the announcement or SEC filing, unless a row says otherwise.
Leadership
- Ajay Singh, Chief Scientific Officer
- Ron Scarboro, Chief Executive Officer
Verified email and direct lines for Azurity Pharmaceuticals’s decision-makers are on Fundz. See plans or book a 15-minute walkthrough.
Employee benefit plans
Azurity Pharmaceuticals files 2 employee benefit plans with the U.S. Department of Labor, including a retirement plan. The next plan year renews in Dec 2026.
Azurity Pharmaceuticals in the news
- PolyPid, Azurity sign surgical site infection drug deal - Reuters (Jul 21, 2026)
- PolyPid, Azurity Pharmaceuticals Agree to Exclusive Commercial Partnership in US and Canada - Contract Pharma (Jul 21, 2026)
- White & Case advises Azurity Pharmaceuticals, Inc. on acquisition of Slayback Pharma, LLC - White & Case LLP (Oct 02, 2023)
- Azurity Pharmaceuticals Acquires Slayback Pharma - BioSpace (Sep 27, 2023)
- Azurity Pharmaceuticals announces the FDA Approval of XIFYRM™ (meloxicam injection) for the Management of Moderate-to-Severe Pain in Adults - PR Newswire (Jun 10, 2025)
- Baclofen Oral Suspension Approved for Treatment of Spasticity in Multiple Sclerosis - NeurologyLive (Feb 07, 2022)
- Azurity Pharmaceuticals, Inc. Announces the Availability of BRYNOVIN™ (sitagliptin), the First and Only Oral Liquid Sitagliptin - PR Newswire (Jul 31, 2025)
- Azurity Pharmaceuticals Completes Acquisition of Covis Pharma - PR Newswire (Mar 14, 2025)
Companies similar to Azurity Pharmaceuticals
- Vectura Group Limited · Biotechnology, Health Care, Manufacturing, Medical, Pharmaceutical
- Lifecore Biomedical · Biotechnology, Health Care, Manufacturing, Medical, Pharmaceutical
- Kaken Pharmaceuticals · Biotechnology, Health Care, Manufacturing, Medical, Pharmaceutical
- Poonglim Pharmatech · Biotechnology, Health Care, Manufacturing, Medical, Pharmaceutical
- Bristol Myers Squibb · Biotechnology, Health Care, Manufacturing, Medical, Pharmaceutical
About Azurity Pharmaceuticals: questions and answers
What does Azurity Pharmaceuticals do?
Azurity is a privately-held pharmaceutical company specializing in providing innovative, high-quality medicines that serve overlooked patients. Azurity supplies a large number of products to treat a wide range of medical conditions. These include cardiovascular, central nervous system, endocrine, gastro-intestinal, anti-infective and oncology medicines. Many of Azurity's medicines are dose-form in
Where is Azurity Pharmaceuticals headquartered?
Azurity Pharmaceuticals is headquartered in Woburn, Massachusetts, United States.
How many employees does Azurity Pharmaceuticals have?
Azurity Pharmaceuticals has about 596 employees.
Who leads Azurity Pharmaceuticals?
Ron Scarboro is a Chief Executive Officer at Azurity Pharmaceuticals.
What is the latest news on Azurity Pharmaceuticals?
On Mar 14, 2025, Azurity Pharmaceuticals Completes Acquisition of Covis Pharma
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy